Melanoma sufferers and cancer groups say Pharmac plans to fund the advanced melanoma drug Keytruda will save lives and change lives. We talk to Pharmac's Sarah Fitt about why Pharmac changed its mind.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
